GlassScriptPhysician profile
Michael C Baloga
NPI 1447632294
$6,739.82
in general payments reported to CMS, 2019-2025
14 companies · $1,478 in 2025
The $1,478 reported for 2025 was more than what 77% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,372 · 2020: $181 · 2021: $2,515 · 2022: $514 · 2023: $435 · 2024: $245 · 2025: $1,478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,172 · Travel and Lodging: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,171.54 |
| Travel and Lodging | $986.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,556.09 | 2019-2025 | Salvation, Hoffmann, Infinity Adaptis |
| Smith+Nephew, INC. | $553.44 | 2020-2025 | Collagenase Santyl, Grafix Pl, Stravix Pl |
| Arthrex, INC. | $258.08 | 2023 | |
| Organogenesis INC. | $59.16 | 2019-2021 | |
| Linvatec Corporation | $56.53 | 2020 | |
| Paragon 28, INC. | $52.31 | 2022-2024 | Trauma, Portfolio |
| Misonix INC | $37.07 | 2020-2021 | |
| Bioventus LLC | $35.17 | 2019-2021 | |
| Orthofix Medical, INC. | $30.55 | 2020-2021 | |
| Novus Surgical Solutions LLC | $29.26 | 2022 | |
| Depuy Synthes Sales INC. | $22.70 | 2023 | Motoband, Va-Lcp |
| Curonix LLC | $17.64 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Treace Medical Concepts, INC. | $15.96 | 2024 | |
| Osiris Therapeutics INC. | $15.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Baloga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.